![](https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg)
Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow
Total revenue increased by 32% to CHF 209m Operating profit tripled to CHF 61m Operating cash flow significantly increased to CHF 74m Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 18, 2025 Basilea Pharmaceutica Ltd, Allschwil …